Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Raw Materials: 2023

Historic Raw Materials for Seres Therapeutics (MCRB) over the last 1 years, with Dec 2023 value amounting to $4.4 million.

  • Seres Therapeutics' Raw Materials rose 802.01% to $4.9 million in Q2 2024 from the same period last year, while for Jun 2024 it was $4.9 million, marking a year-over-year increase of 802.01%. This contributed to the annual value of $4.4 million for FY2023, which is N/A change from last year.
  • Latest data reveals that Seres Therapeutics reported Raw Materials of $4.4 million as of FY2023.
  • In the past 5 years, Seres Therapeutics' Raw Materials registered a high of $4.4 million during FY2023, and its lowest value of $4.4 million during FY2023.
  • For the 1-year period, Seres Therapeutics' Raw Materials averaged around $4.4 million, with its median value being $4.4 million (2023).